or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    VINC F Vincera Pharma, Inc. -1.56
    PRLD F Prelude Therapeutics Incorporated -1.91
    CARM F Carisma Therapeutics, Inc. -2.98
    AFMD F Affimed Therapeutics B.V. -0.76
    GMAB F Genmab A/S 0.88
    TCBP F TC BioPharm (Holdings) plc -0.94
    MTEM F Molecular Templates, Inc. -11.76
    BPTH F Bio-Path Holdings Inc 2.63
    APTO F Aptose Biosciences, Inc. -22.13
    TSBX F Turnstone Biologics Corp. 2.47
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biopharmaceutical Medicine Biotechnology Clinical Medicine Autoimmune Disease Biology Cancer Therapies Cancer Treatment Gene Therapy Immune System Abdominal Pain Amines Anaplastic Lymphoma Kinase Antineoplastic Drugs Atopic Dermatitis Autoimmunity Bemcentinib Blood Test Brain Tumor

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    QQQS B Invesco NASDAQ Future Gen 200 ETF 0.64
    IWC B iShares Microcap ETF 0.13
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 0.13
    FESM B Fidelity Enhanced Small Cap ETF 0.08
    RFLR B Innovator U.S. Small Cap Power Buffer ETF - September Innovator U.S. Small Cap Managed Floor ETF 0.03
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare BBC to RFLR Compare FESM to RFLR Compare QQQS to FESM

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 22 APTO S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results
        Nov 22 APTO Aptose Biosciences to sell 40M shares at $0.20 in public offering
        Nov 22 APTO Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 BPTH Bio-Path Holdings Inc (BPTH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial ...
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
        Nov 17 CARM Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Medicine Clinical Medicine Biopharmaceutical Cancer Immunotherapy Cancer Treatment Acute Myeloid Leukemia Biotechnology Drugs Epidermal Growth Factor Receptor Head And Neck Cancer Hematologic Malignancies Hematological Malignancies Immunotherapy Lymphoma Melanoma Monoclonal Antibodies Oncology Peptides Treatment Of A Range Of Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags